KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Dividends Paid - Common Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div. Paid (Common) Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 15.01%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 4.75%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 5.50%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 2.68%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 6.18%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 3.59%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 0.33%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 1.99%
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.18%
Dec 31, 2025 6.47%
Sep 30, 2025 5.95%
Jun 30, 2025 5.87%
Mar 31, 2025 5.88%
Dec 31, 2024 5.70%
Sep 30, 2024 6.14%
Jun 30, 2024 6.15%
Mar 31, 2024 6.24%
Dec 31, 2023 9.62%
Sep 30, 2023 9.83%
Jun 30, 2023 9.73%
Mar 31, 2023 5.28%
Dec 31, 2022 5.05%
Sep 30, 2022 3.90%
Jun 30, 2022 2.98%
Mar 31, 2022 6.30%
Dec 31, 2021 6.22%
Sep 30, 2021 6.73%
Jun 30, 2021 7.01%
Mar 31, 2021 7.51%
Dec 31, 2020 8.37%
Sep 30, 2020 7.83%
Jun 30, 2020 7.05%
Mar 31, 2020 4.88%
Dec 31, 2019 2.38%
Sep 30, 2019 2.00%
Jun 30, 2019 1.73%
Mar 31, 2019 -5.26%
Dec 31, 2018 0.72%
Sep 30, 2018 1.55%
Jun 30, 2018 2.25%
Mar 31, 2018 12.28%
Dec 31, 2017 11.65%
Sep 30, 2017 12.18%
Jun 30, 2017 12.50%
Mar 31, 2017 12.63%
Dec 31, 2016 25.34%
Sep 30, 2016 24.71%
Jun 30, 2016 24.92%
Mar 31, 2016 25.54%
Dec 31, 2015 28.45%
Sep 30, 2015 29.09%
Jun 30, 2015 30.02%
Mar 31, 2015 30.22%
Dec 31, 2014 31.07%
Sep 30, 2014 31.07%
Jun 30, 2014 30.79%
Mar 31, 2014 30.31%
Dec 31, 2013 29.20%
Sep 30, 2013 26.88%
Jun 30, 2013 26.43%
Mar 31, 2013 23.86%
Dec 31, 2012 11.84%
Sep 30, 2012 9.41%